医疗保健成本和资源利用在支气管切除症,喘和慢性肺炎
Raffaella Ronco1,2, Giovanni Franco3, Matteo Monzio Compagnoni1,2
1National Centre for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy.
ERJ open research
|August 2, 2023
概括
喘患者的直接医疗费用降低了52%,而COPD患者的费用比支气管切除症患者高出41%. 住院治疗和抗生素是支气管切除症的主要费用.
科学领域:
- 肺部病理学 肺部病理学
- 卫生经济学 卫生经济学
背景情况:
- 支气管切除症,喘和慢性阻塞性肺病 (COPD) 是慢性呼吸道疾病,具有显著的医疗负担.
- 了解与这些疾病相关的比较直接医疗保健成本对于资源配置和医疗保健政策至关重要.
研究的目的:
- 将支气管切除症患者的直接医疗费用与喘和COPD患者的直接医疗费用进行比较.
- 确定支气管切除症中医疗保健支出的主要驱动因素.
主要方法:
- 追溯分析医疗保健索赔数据.
- 患者队列之间的直接医疗成本的比较:支气管切除症,喘和COPD.
- 确定支气管切除症患者的主要成本类别.
主要成果:
- 与支气管切除症患者相比,喘患者的直接医疗费用降低了52%.
- 与支气管切除症患者相比,COPD患者的直接医疗费用比支气管切除症患者高41%.
- 住院和使用抗生素是支气管切除症患者的主要成本驱动因素.
结论:
- 喘和COPD与支气管切除相比,呈现出不同的直接医疗费用概况.
- 针对住院和抗生素管理的有针对性的干预措施可能会降低支气管切除症管理的成本.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
244
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
244
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K


